Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Clinical Immunology
Appendix
Available only for authorised users
Literature
1.
Bonilla FA. Update: Vaccines in primary immunodeficiency. J Allergy Clin Immunol. 2018;141(2):474–81.CrossRef
2.
Burton RL, Antonello J, Cooper D, Goldblatt D, Kim KH, Plikaytis BD, et al. Assignment of opsonic values to pneumococcal reference serum 007sp for use in opsonophagocytic assays for 13 serotypes. Clin Vaccine Immunol. 2017;24(2):e00457-e516.CrossRef
3.
Centers for Disease Control and Prevention. Licensure of 13-valent pneumococcal conjugate vaccine for adults aged 50 years and older. Morb Mortal Wkly Rep. 2012;61(21):394–5.
4.
LaFon DC, Putcha N, Hansel N, Azar A, Han MK, Krishnan JA, Ortega VE, Barjaktarevic I, Curtis JL, Kaner RJ, Nahm MH, Dransfield MT. Reduced pneumococcal antibody function is associated with exacerbations Of COPD In SPIROMICS. Am J Respir Crit Care Med. 2020.(Online abstracts issue). 201:A2549. Poster discussion at ATS Virtual Conference, August 2020.
5.
Hare ND, Smith BJ, Ballas ZK. Antibody response to pneumococcal vaccination as a function of preimmunization titer. J Allergy Clin Immunol. 2009;123(1):195–200.CrossRef
6.
Jackson LA, El Sahly HM, George S, Winokur P, Edwards K, Brady RC, et al. Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine. 2018;36(5):606–14.CrossRef
7.
World Health Organization. Pneumococcal vaccines WHO position paper - 2012 - recommendations. Vaccine. 2012;30(32):4717–8.CrossRef
8.
Sorensen RU, Leiva LE, Javier FC 3rd, Sacerdote DM, Bradford N, Butler B, et al. Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations. J Allergy Clin Immunol. 1998;102(2):215–21.CrossRef
9.
Lee H, Nahm MH, Burton R, Kim KH. Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A. Clin Vaccine Immunol. 2009;16(3):376–81.CrossRef
Metadata
Title
Pneumococcal Antibody Function for Immunologic Evaluation: Normal Results in Older Adults, and a Novel Analytical Model for Vaccine Response
Authors
David LaFon
Young-il Kim
Robert Burton
Mark Dransfield
Moon Nahm
Publication date
01-11-2021
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 8/2021
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-021-01126-z

Other articles of this Issue 8/2021

Journal of Clinical Immunology 8/2021 Go to the issue

Letter to Editor

Anti-voltage-Gated Potassium Channel (VGKC) Antibodies and Acquired Neuromyotonia in Patients with Immune Dysregulation, Polyendocrinopathy, Enteropathy X-Lined (IPEX) Syndrome

Original Article

Determinants and Reference Ranges of Serum Immunoglobulins in Middle-Aged and Elderly Individuals: a Population-Based Study

Original Article

Chromatin Modifications in 22q11.2 Deletion Syndrome

Letter to Editor

Prolonged Fecal Shedding of SARS-CoV-2 in Asymptomatic Children with Inborn Errors of Immunity

Letter to Editor

Self-Limited COVID-19 in a Patient with Artemis Hypomorphic SCID

Original Article

Genetic Analysis of a Cohort of 275 Patients with Hyper-IgE Syndromes and/or Chronic Mucocutaneous Candidiasis

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits